Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer

Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer

As survival in breast cancer patients from newer therapies increases, concerns for chemotherapy-induced cardiotoxicity (CIC) have offset some of these benefits, manifesting as a decline in left ventricular ejection fraction (LVEF). Patients receiving anthracycline-based chemotherapy followed by tras...

Full description

Bibliographic Details
Main Authors: Krithika Krishnarao, Katelyn A. Bruno, Damian N. Di Florio, Brandy H. Edenfield, Emily R. Whelan, Logan P. Macomb, Molly M. McGuire, Anneliese R. Hill, Jordan C. Ray, Lauren F. Cornell, Winston Tan, Xochiquetzal J. Geiger, Gary R. Salomon, Erika J. Douglass, DeLisa Fairweather, Mohamad H. Yamani
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Clinical Medicine
Subjects:
biomarkers
chemotherapy-induced cardiotoxicity
angiotensin II type I receptor
endothelin 1
Online Access:https://www.mdpi.com/2077-0383/11/12/3547

Internet

https://www.mdpi.com/2077-0383/11/12/3547

Similar Items